Man who died of Ebola-like Marburg virus in Guinea may have spread it to 155 others, health chiefs fear

  • Health chiefs in Guinea are monitoring 155 people who may have Marburg virus
  • A man who died of the virus last week, but others cases haven't been spotted
  • The virus causes people to bleed internally and from body openings
  • Health authorities in Guinea are monitoring 155 people they fear may have caught a deadly Ebola-like disease.

    One man has already died from Marburg virus, prompting a desperate scramble to find everyone he came into contact with. 

    All of the people he met have now been traced and told to self-isolate. They are also being kept under observation for three weeks. The case, detected last week in Gueckedou, marked the first time the virus has been spotted in West Africa. 

    No other cases have been detected yet — but the World Health Organization warned the affected village is near the country's border with Sierra Leone and Liberia.

    Marburg is one of the deadliest pathogens known to exist, killing between half and 90 per cent of everyone who gets infected.   

    The virus is carried by fruit bats but can be spread between humans through blood and bodily fluids, as well as touching contaminated surfaces. 

    Infected patients can resemble ghosts, with deep-set eyes and expressionless faces, according to the WHO. Other symptoms include headache, diarrhoea, stomach pain and vomiting.

    After five days, many patients start to bleed under the skin, in internal organs or from openings such as the mouth, eyes and ears. Patients often die from nervous system failure, not blood loss.

    The map shows the location of previous Marburg virus outbreaks (marked with stars) and countries that have experienced Marburg haemorrhagic fever outbreaks. It also displays countries with imported cases of the virus in humans (in light orange), including North America and South Africa, and countries that have experienced outbreaks after infected monkeys have been imported (orange), such as in Germany

    The map shows the location of previous Marburg virus outbreaks (marked with stars) and countries that have experienced Marburg haemorrhagic fever outbreaks. It also displays countries with imported cases of the virus in humans (in light orange), including North America and South Africa, and countries that have experienced outbreaks after infected monkeys have been imported (orange), such as in Germany. The purple dotted line shows where the bats that can transmit the virus are found, including parts of Africa, Australia and China


    What is Marburg virus? 

    Marburg virus causes a severe and highly fatal haemorrhagic fever that often kills whoever catches it.

    Initial symptoms include a severe headache, a high fever, diarrhoea, stomach pain and vomiting and become increasingly severe.

    In the early stages of the disease, it is very difficult to distinguish from other tropical illnesses that cause fevers, such as Ebola and malaria.

    After five days, many patients start to bleed under the skin, in internal organs or from body opening such as the mouth, eyes and ears.

    There is currently no cure for the disease, so patients are monitored and treated with fluids. 

    Studies are currently trialling antibody treatments and antivirals, but these can only be given as part of the trials, according to WHO. 

    Patients then die from nervous system failure and the fatality rate is 50 per cent, according to World Health Organization estimates.

    Marburg fatality rates in past outbreaks have varied from 24 per cent to 88 per cent of those infected. 

    It is initially transmitted to humans through exposure to mines or caves inhabited by Rousettus bats and it is then spread through direct contact with infected people's bodily fluids or surfaces and materials contaminated with these fluids. 


    The WHO announced yesterday that Guinea's Ministry of Health informed it of a suspected case on August 6.

    The man started experiencing symptoms on July 25 and went to a local health facility near his village on August 1 with a headache, tiredness, stomach pain and bleeding gums.

    He was treated with rehydration and antibiotics but died on August 2.

    A team of WHO and local experts were deployed on August 3 and confirmed through a test that the man had Marburg virus disease.

    Two labs subsequently confirmed the positive test result.

    Experts are now working to identify the source of the outbreak and searching for more possible contacts.

    Dr Georges Ki-Zerbo, the WHO's country head in Guinea, said Marburg had been circulating in animals, particularly bats, in southern Guinea and neighbouring Sierra Leone and Liberia.

    Pathogens have tended to cross from animals to humans in the region because of their close interaction, notably in the hunting and eating of 'bushmeat' from the wild. 

    Dr Ki-Zerbo said: 'There is no known secondary case. The contacts have been traced, and 155 people are under observation for three weeks.

    'It is active surveillance. The contacts are kept at home, isolated from other members of the family. They are visited every day to check on potential symptoms.'

    Marburg and Ebola are closely related.

    Guinea was declared free of Ebola two months ago, following an outbreak that killed 12 people.

    Gueckedou was the origin of the 2014-2016 West Africa Ebola outbreak, the deadliest in history, and saw a brief resurgence of Ebola this year. 

    Dr Ki-Zerbo said Guinea was better prepared to handle an outbreak than it had been when Ebola struck in 2014. The discovery of the Marburg case also indicated improved ability to detect such infections.

    He said Guinea has built a 'robust health security system' since the last Ebola outbreak, including the use of rapid response teams, disease detectives, epidemiologists and social anthropologists, and better coordination with neighbouring countries.

    He added: 'Globally, the approach to combating Marburg would not be different from Ebola.

    'The only difference is that there is no vaccine or drug specifically directed to the virus. Only supportive care is available.' 

    The WHO warned the country has a 'fragile healthcare system', which is exacerbated by disease outbreaks and the Covid pandemic.


No comments:

Powered by Blogger.